SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 23,634,349 | $149,133,000 | 99.87% |
| Perceptive Advisors | 4,762,472 | $30,052,000 | 1.24% |
| QVT Financial LP | 1,750,285 | $11,044,000 | 0.75% |
| NBW CAPITAL LLC | 404,721 | $2,554,000 | 0.45% |
| Tekla Capital Management LLC | 489,750 | $3,090,000 | 0.34% |
| MILES CAPITAL, INC. | 57,904 | $365,000 | 0.21% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 435,200 | $2,746,000 | 0.16% |
| Old West Investment Management, LLC | 49,136 | $310,000 | 0.15% |
| Integre Asset Management, LLC | 84,420 | $533,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 250,952 | $1,584,000 | 0.10% |